U.S. health authorities are signing off on human trials of CBD to treat opioid addiction. The U.S. Food and Drug Administration gave the green light this week to Ananda Scientific to start human testing of its CBD drug Nantheia ATL5, the company announced. The trials will be run out of UCLA and are funded by
Infused Products & Extraction
Editor’s note: This week, Hemp Industry Daily will be highlighting stories and analysis on the delta-8 THC phenomenon. Today, a look at the origins of the delta-8 THC trend. Read more in the special D-8 February issue of MJBiz Magazine. When Harold Jarboe told his partners at Columbia River Cannabis in 2014 that he was
Editor’s note: This week Hemp Industry Daily is highlighting stories and analysis on the delta-8 THC phenomenon. Today, a look at delta-8 THC sales trends in marijuana dispensaries. Read more in the special D-8 February issue of MJBizMagazine. Plant-touching companies weren’t the only businesses surprised by the sudden and explosive growth of delta-8 THC in
No part of the global economy has escaped the COVID-19 pandemic, which has claimed more than 2.5 million lives around the world and sickened countless more. But few industries were in the kind of infancy the hemp industry was in when the World Health Organization declared the virus a global pandemic on March 11, 2020.
(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Jackie Berg is co-founder of CBD Marketing Hub, a digital-to-door agency focused on CBD and cannabis marketing.) Sleep is valued commodity and something many Americans are increasingly bereft of. Many health experts see sleep issues as
MJBizCon will return as a live, in-person event in Las Vegas this October, barring any unforeseen developments related to the coronavirus pandemic, Marijuana Business Daily announced Monday. The 10th annual cannabis trade show, the largest in the industry, is scheduled to be held at the Las Vegas Convention Center and will include an online component
(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Julie Lerner is CEO of PanXchange, a commodity trading platform and benchmark price provider.) Basing the multibillion-dollar, pie-in-the-sky forecasts for the U.S. addressable market for CBD on retail shelf prices disturbs me. It’s as illogical as
North Carolina CBD maker cbdMD has hired Sibyl Swift, a former U.S. Food and Drug Administration official as a consultant to lead the company’s regulatory efforts and prepare products for certifications. Swift served in various roles at the FDA from 2014 to 2020, most notably as the associate director for research and strategy in the
A bipartisan bill that was introduced in the U.S. House of Representatives Thursday could push legal CBD through Congress, providing consumer access and protection while clearing the supply chain bottleneck. The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 is sponsored by Representatives Kurt Schrader, a Democrat from Oregon, and Morgan
A key market regulator for trade in the European Union has updated its guidelines to add plant-derived CBD as a legal ingredient in cosmetics. The change comes after the European Industrial Hemp Association pointed out that the European Court of Justice recently ruled that CBD should not be classified as a drug and can be
Thailand’s public health minister has approved regulations legalizing hemp production beginning Friday. The new rules allows hemp cultivation for commercial, medicinal, and research purposes, the Bangkok Post reported. Public Health Minister Anutin Charnvirakul approved the rules Thursday. The regulations will allow both exports and imports and the plant can be cultivated for extracts, beverages, cosmetics,
If the CBD market is any indication of how other sectors will be affected by the United Kingdom’s divorce from the European Union, buckle your seatbelts. Supply-chain slowdowns and lockdowns due to the Covid-19 pandemic have already made doing business in the UK a challenge. Now, with the confusion surrounding the final Brexit trade deal,
RAMM Pharma, a cannabis-based pharmaceutical company with products in several Latin American countries, has bought a 49% stake in the Sicilian CBD processing company Canapar. Based in Toronto, RAMM purchased the shares from the cannabis venture-capital firm Canopy Rivers. Under the agreement, RAMM paid $7 million cash to Canopy Rivers to buy a little more
California lawmakers will be faced again with the long-debated question of whether to allow hemp extracts in food and beverages in the state when the legislative session opens Monday, but this time the proposal comes with a twist: The measure would also ban smokable hemp flower – an increasingly popular and unregulated segment of the industry.
A longer version of this story appears at Marijuana Business Daily International. Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the launch of GW Pharmaceuticals’ CBD drug Epidiolex. Overall sales of all medial cannabis products grew from about 13 million Danish Krones ($2 million) in the
This story appears in the January issue of Marijuana Business Magazine. Acquisitions remain a key strategy for companies looking to enter or expand their reach within the cannabis industry, but sellers must be ready to seize such opportunities. Owners who would like to exit the hemp space or join larger conglomerates should be ready to: Decide whether to engage a broker. Ensure their financial information is ready for close
BastCore, an Alabama-based hemp fiber company, has turned a former steam plant outside the capital of Montgomery into a processing facility, one of the first in the United States to offer a key link in the supply chain between Alabama’s farmers and hemp-derived product makers. Final electrical work was underway inside the processing facility last
Charlotte’s Web Holdings says that labeling lawsuits against CBD makers must wait while federal regulators consider how to regulate the hemp extract. The company made the argument last week in a federal court in California, where it is asking a judge to follow the direction of other federal judges and dismiss CBD labeling suits as